Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9CFH

Cryo-EM Refinement of Antibody 19-77 R71V in complex with SARS-CoV-2 JD.1.1 RBD

Summary for 9CFH
Entry DOI10.2210/pdb9cfh/pdb
EMDB information45546
DescriptorSpike protein S1, heavy chain, light chain (3 entities in total)
Functional Keywordsneutralizing antibody, viral fusion protein, sars-cov-2, viral protein-immune system complex, viral protein, viral protein/immune system
Biological sourceSevere acute respiratory syndrome coronavirus 2
More
Total number of polymer chains3
Total formula weight49152.29
Authors
Casner, R.G.,Shapiro, L. (deposition date: 2024-06-27, release date: 2025-07-02, Last modification date: 2025-10-01)
Primary citationWang, Q.,Guo, Y.,Casner, R.G.,Yu, J.,Nair, M.S.,Ho, J.,Reddem, E.R.,Mellis, I.A.,Wu, M.,Tzang, C.C.,Hong, H.,Huang, Y.,Shapiro, L.,Liu, L.,Ho, D.D.
Optimizing a human monoclonal antibody for better neutralization of SARS-CoV-2.
Nat Commun, 16:6195-6195, 2025
Cited by
PubMed Abstract: SARS-CoV-2 has largely evolved to resist antibody pressure, with each successive viral variant becoming more and more resistant to serum antibodies in the population. This evolution renders all previously authorized anti-spike therapeutic monoclonal antibodies inactive, and it threatens the remaining pipelines against COVID-19. We report herein the isolation of a human monoclonal antibody with a broad but incomplete SARS-CoV-2 neutralization profile, but structural analyses and mutational scanning lead to the engineering of variants that result in greater antibody flexibility while binding to the viral spike. Three such optimized monoclonal antibodies neutralize all SARS-CoV-2 strains tested with much improved potency and breadth, including against subvariants XEC and LP.8.1. The findings of this study not only present antibody candidates for clinical development against COVID-19, but also introduce an engineering approach to improve antibody activity via increasing conformational flexibility.
PubMed: 40615407
DOI: 10.1038/s41467-025-61472-z
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.1 Å)
Structure validation

243531

PDB entries from 2025-10-22

PDB statisticsPDBj update infoContact PDBjnumon